Choose your language:
Facebook
LinkedIn
Twitter

Ross McDowall

BlueMount Capital Turns 10!

This year, BlueMount Capital is proudly celebrating its 10th anniversary of providing Global Capital Solutions. It’s our commitment to providing valuable relationships which has given us the capacity to continually deliver comprehensive solutions for the most sophisticated business requirements across all asset classes. Continue reading

How Does a Stock Move from the OTC to a Major Exchange?

There are many reasons why a company may trade on the Over the Counter (OTC), which unlike a standard exchange, has no physical location, but it’s not an option that provides much exposure or even a lot of liquidity. Trading on a major  exchange, though, does. But is there a way for companies to move from one to the other?

Key Takeaways

  • OTC securities are not listed on an exchange, but trade through a broker-dealer network.
  • Companies can jump from the OTC market to a major exchange as long as they meet listing and regulatory requirements, which vary by exchange.
  • Exchanges must approve a company’s application to list, which should be accompanied by financial statements.
  • Some companies choose to move to get the visibility and liquidity provided by a stock exchange.
  • Dual listing ,by staying on the OTC and dual listing on a major exchange is a great option and is possible.

Continue reading

BlueMount Capital in the news: “Brave new world: Islamic finance in BD“

International IFN Roadshow Bangladesh-2021 was held recently organised by REDMoney Group. The IFN Roadshow-2021 series opens with Bangladesh, a country that has a promising future in Islamic finance, especially as it launched its first corporate Sukuk in 2020. Bangladesh is on a sprint to aggressive development as the public demand for Islamic finance is rising, which has spurred the robust Islamic banking sector in the nation. Continue reading

BlueMount Capital in the news: “Altech Chemicals finalises $195m green bond offering to fund Malaysian high purity alumina plant”

Altech Chemicals (ASX: ATC) has entered the final stages of a $195 million listed green bond offering to provide additional financing for the construction of a planned $400 million high purity alumina (HPA) plant in Malaysia.

The company has been working with UK structuring agent Bedford Row Capital PLC and Perth-based Bluemount Capital since October to prepare for the offering. Continue reading

BlueMount Capital in the news: “Bangladesh: Could corporate Sukuk take off?” IFN 17th March 2021

“Bangladesh turns 50 this month, and in a fitting celebration, March 2021 also saw the country’s first corporate Sukuk announced: a US$250 million issuance from Deshbandhu Group (DGL) expected to mature in 2028. Following on from the government’s first debut sovereign Sukuk back in December 2020, the move is an encouraging one as the economy gathers steam. But with significant barriers remaining to a conducive issuing environment, can Bangladesh maintain its momentum? LAUREN MCAUGHTRY speaks to the lead arranger of the deal to learn more. Continue reading

The Secret to a Successful IPO

There are many measures of success for initial public offerings (IPOs). First and foremost is completing the deal and raising the intended proceeds. From the perspective of remaining and new shareholders, however, the subsequent short-term trading performance is more often seen as the measure of a good IPO as opposed to a bad one.

For the board and management of the newly listed entity, their measure of success and their reputation will depend on how well the newly listed entity performs in the medium term and delivers on the investment proposition on which new shareholders based their investment decision. Continue reading

Technology and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in a corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Companies consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. Continue reading

Healthcare and International Stock Exchange Listings for US companies

An IPO is often the most important capital markets and wealth creation event in your corporate life cycle. Unmatched access to capital at a lower cost is a clear benefit in favour of an IPO, along with corporate branding opportunities and a host of other benefits.

Your company should consider three things when choosing a listing location—the actual out-of-pocket costs for establishing and maintaining the listing, the effects on valuation and liquidity, and the nonfinancial benefits. (A fuller discussion of the pros and cons of listing on the Australian Securities Exchange (ASX) versus the Nasdaq or NYSE can be found in the second of this series of BlueMount Capital’s articles: “International Stock Exchange Listings for US Companies”.) Continue reading